Efficacy of the hypoxia-activated prodrug evofosfamide (TH-302) in nasopharyngeal carcinoma in vitro and in vivo

Overview of attention for article published in Cancer Communications, May 2018

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (51st percentile)

Mentioned by

wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 26 Dimensions

Readers on

mendeley: 22 Mendeley

Summary Wikipedia Dimensions citations

So far, Altmetric has seen 1 Wikipedia article.

English

Evofosfamide

Cited by user Tahreemasghar on 09 May 2022

Evofosfamide (INN, USAN; formerly known as TH-302) is an investigational hypoxia-activated prodrug that is in clinical development for cancer treatment.

This page shows the most recent Wikipedia articles that mention this research output.

Click here to find out how to access more activity.